Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy (Review)
Open Access
- 3 October 2019
- journal article
- review article
- Published by Spandidos Publications in Oncology Letters
- Vol. 18 (6) , 5699-5708
Abstract
Breast cancer is the most common malignant neoplasm in women worldwide, and the treatment regimens currently available are far from optimal. Targeted therapy, based on molecular typing of breast cancer, is the most precise form of treatment, and CXC chemokine receptor 2 (CXCR2) is one of the molecular markers used in targeted therapies. As a member of the seven transmembrane G‑protein‑coupled receptor family, CXCR2 and its associated ligands have been increasingly implicated in tumor‑associated processes. These processes include proliferation, angiogenesis, invasion, metastasis, chemoresistance, and stemness and phenotypic maintenance of cancer stem cells. Thus, the inhibition of CXCR2 or its downstream signaling pathways could significantly attenuate tumor progression. Therefore, studies on the biological functions of CXCR2 and its association with neoplasia may help improve the prognosis of breast cancer. Furthermore, the targeting of CXCR2 could supplement the present clinical approaches of breast cancer treatment strategies. The present review discusses the structures and mechanisms of CXCR2 and its ligands. Additionally, the contribution of CXCR2 to the development of breast cancer and its potential therapeutic benefits are also discussed.Keywords
This publication has 118 references indexed in Scilit:
- Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisBritish Journal of Cancer, 2012
- Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptorCancer Letters, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesCancer Letters, 2011
- Chemokine Signaling Specificity: Essential Role for the N-Terminal Domain of Chemokine ReceptorsBiochemistry, 2007
- G protein coupled receptor structure and activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971